Encompass Health Corporation (EHC) Stock Forecast
EHC analyst forecast
as of October 18, 2026- Analyst consensus
- Strong buy 4.92 / 5 from 13 analysts
- Price target
- $148.17 average of analyst targets
- Upside to target
- +15.9% from the latest close
- Next earnings
- October 28, 2026 EPS estimate $1.37
- 52-week range
- $93.83 – $127.87
EHC analyst ratings
13 analystsNumber of analysts at each rating.
EHC price target
The average of analyst 12-month price targets compared with the latest close and the 52-week range.
EHC earnings per share estimates
| Period | Average | Low | High | Year ago | Growth | Analysts |
|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | $1.36 | $1.25 | $1.41 | $1.23 | +10.4% | 12 |
| Current fiscal year (2026) | $6.11 | $5.84 | $6.19 | $5.45 | +12.1% | 13 |
| Next fiscal year (2027) | $6.68 | $6.15 | $6.88 | $6.11 | +9.3% | 13 |
Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.
EHC revenue estimates
| Period | Average | Low | High | Growth | Analysts |
|---|---|---|---|---|---|
| Current quarter (Sep '26) | $1.60B | $1.59B | $1.62B | +8.4% | 11 |
| Current fiscal year (2026) | $6.46B | $6.44B | $6.48B | +8.8% | 12 |
| Next fiscal year (2027) | $6.99B | $6.95B | $7.04B | +8.3% | 12 |
EHC EPS: reported and forecast
Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.
EHC revenue: reported and forecast
EHC EPS estimate revisions
| Period | 90 days ago | 60 days ago | 30 days ago | 7 days ago | Now | Change (90 d) | Revisions (30 d) |
|---|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | $1.36 | $1.36 | $1.36 | $1.36 | $1.36 | −0.1% | 8 up · 4 down |
| Current fiscal year (2026) | $6.01 | $6.11 | $6.11 | $6.11 | $6.11 | +1.8% | 0 up · 1 down |
| Next fiscal year (2027) | $6.54 | $6.68 | $6.68 | $6.68 | $6.68 | +2.2% | 10 up · 2 down |
How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.
EHC earnings surprises
Reported EPS vs the consensus estimate for the last 12 quarters; EHC beat in 12 of 12.
What analysts expect from EHC
13 analysts cover Encompass Health; their consensus rating is strong buy (4.92 on a 1–5 scale, where 5 is a strong buy). The average price target is $148.17, 15.9% above the latest close of $127.87. Analysts expect earnings of $6.11 per share for 2026, +12.1% from a year earlier. For 2027 the average estimate is $6.68 per share on revenue of $7.0 billion. Encompass Health beat the EPS estimate in 12 of the last 12 quarters.
Related: EHC income statement, EHC key metrics, EHC chart. See the EHC stock overview for the latest quote and news.
EHC forecast FAQ
What is Encompass Health's price target?
The average analyst price target for Encompass Health is $148.17, 15.9% above the latest close of $127.87.
Is Encompass Health a buy, hold or sell?
Of 13 analysts covering Encompass Health, 12 rate it a strong buy, 1 a buy, 0 a hold, 0 a sell and 0 a strong sell, a consensus of strong buy. Ratings are opinions, not a recommendation from Quotelinks.
What is Encompass Health's EPS forecast?
Analysts forecast $6.11 per share for 2026 (range $5.84 to $6.19); for 2027 the estimate is $6.68.
What is Encompass Health's revenue forecast?
The average revenue estimate for 2026 is $6.5 billion, growth of 8.8%; for 2027 it is $7.0 billion.
When does Encompass Health report earnings?
Encompass Health is expected to report results for the quarter ending September 30, 2026 on October 28, 2026 after the market closes; the EPS estimate is $1.37.
Does Encompass Health usually beat earnings estimates?
Encompass Health reported EPS at or above the analyst estimate in 12 of the last 12 quarters.